| 0 |
PSEUDOCELLULITIS |
92 |
0.4299 |
| 1 |
EROSIVE PUSTULAR DERMATOSIS |
21 |
0.4200 |
| 2 |
LUNG ADENOCARCINOMA RECURRENT |
21 |
0.2039 |
| 3 |
MALIGNANT NEOPLASM OLIGOPROGRESSION |
28 |
0.1407 |
| 4 |
SCLERODERMA-LIKE REACTION |
22 |
0.1392 |
| 5 |
AUTOIMMUNE LUNG DISEASE |
16 |
0.1356 |
| 6 |
EGFR GENE MUTATION |
50 |
0.1337 |
| 7 |
IMMUNE-MEDIATED PNEUMONITIS |
29 |
0.1239 |
| 8 |
LUNG ADENOCARCINOMA STAGE IV |
45 |
0.1181 |
| 9 |
IMMUNE-MEDIATED LUNG DISEASE |
200 |
0.1096 |
| 10 |
NON-SMALL CELL LUNG CANCER METASTATIC |
88 |
0.1001 |
| 11 |
MELANODERMA |
19 |
0.0990 |
| 12 |
NON-SMALL CELL LUNG CANCER RECURRENT |
27 |
0.0954 |
| 13 |
NON-SMALL CELL LUNG CANCER |
428 |
0.0893 |
| 14 |
IMMUNE-MEDIATED CHOLANGITIS |
31 |
0.0864 |
| 15 |
IMMUNE-MEDIATED RENAL DISORDER |
35 |
0.0845 |
| 16 |
MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME |
19 |
0.0833 |
| 17 |
IMMUNE-MEDIATED DERMATITIS |
84 |
0.0833 |
| 18 |
LUNG ADENOCARCINOMA METASTATIC |
19 |
0.0815 |
| 19 |
FEBRILE BONE MARROW APLASIA |
323 |
0.0759 |
| 20 |
IMMUNE-MEDIATED GASTRITIS |
14 |
0.0729 |
| 21 |
AUTOIMMUNE NEPHRITIS |
16 |
0.0727 |
| 22 |
ACQUIRED GENE MUTATION |
95 |
0.0725 |
| 23 |
DERMO-HYPODERMITIS |
43 |
0.0721 |
| 24 |
MALIGNANT TRANSFORMATION |
32 |
0.0713 |
| 25 |
BRONCHIAL FISTULA |
14 |
0.0693 |
| 26 |
IMMUNE-MEDIATED HYPOTHYROIDISM |
78 |
0.0691 |
| 27 |
IMMUNE-MEDIATED ARTHRITIS |
26 |
0.0682 |
| 28 |
HYPERCREATININAEMIA |
34 |
0.0676 |
| 29 |
IMMUNE-MEDIATED HEPATIC DISORDER |
129 |
0.0661 |
| 30 |
RADIATION OESOPHAGITIS |
25 |
0.0656 |
| 31 |
THROMBOPHLEBITIS MIGRANS |
22 |
0.0647 |
| 32 |
TUMOUR ASSOCIATED FEVER |
26 |
0.0636 |
| 33 |
NON-SMALL CELL LUNG CANCER STAGE IV |
23 |
0.0630 |
| 34 |
IMMUNE-MEDIATED HEPATITIS |
128 |
0.0626 |
| 35 |
IMMUNE-MEDIATED ENTEROCOLITIS |
230 |
0.0625 |
| 36 |
IMMUNE-MEDIATED NEPHRITIS |
29 |
0.0618 |
| 37 |
LUNG ADENOCARCINOMA |
179 |
0.0594 |
| 38 |
TUMOUR PSEUDOPROGRESSION |
65 |
0.0594 |
| 39 |
IMMUNE-MEDIATED HYPERTHYROIDISM |
15 |
0.0591 |
| 40 |
PERIPHERAL VEIN THROMBOSIS |
14 |
0.0586 |
| 41 |
TUMOUR HYPERPROGRESSION |
14 |
0.0565 |
| 42 |
PENILE ULCERATION |
18 |
0.0550 |
| 43 |
PLEURAL MESOTHELIOMA MALIGNANT |
17 |
0.0550 |
| 44 |
LICHENOID KERATOSIS |
125 |
0.0547 |
| 45 |
METASTASES TO ADRENALS |
49 |
0.0531 |
| 46 |
AUTOIMMUNE COLITIS |
34 |
0.0527 |
| 47 |
IMMUNE-MEDIATED PANCREATITIS |
20 |
0.0525 |
| 48 |
MYASTHENIC SYNDROME |
38 |
0.0491 |
| 49 |
LYMPHANGIOSIS CARCINOMATOSA |
51 |
0.0489 |
| 50 |
IMMUNE-MEDIATED ADRENAL INSUFFICIENCY |
39 |
0.0489 |
| 51 |
SUPERIOR VENA CAVA SYNDROME |
29 |
0.0480 |
| 52 |
IMMUNE-MEDIATED MYOCARDITIS |
77 |
0.0476 |
| 53 |
PARANEOPLASTIC SYNDROME |
31 |
0.0459 |
| 54 |
EPIDERMOLYSIS |
21 |
0.0457 |
| 55 |
EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED |
55 |
0.0441 |
| 56 |
METASTASES TO THE MEDIASTINUM |
18 |
0.0437 |
| 57 |
ADRENOCORTICOTROPIC HORMONE DEFICIENCY |
38 |
0.0433 |
| 58 |
NEPHRITIS |
143 |
0.0428 |
| 59 |
MALIGNANT PLEURAL EFFUSION |
72 |
0.0427 |
| 60 |
RADIATION PNEUMONITIS |
91 |
0.0425 |
| 61 |
APLASIA |
81 |
0.0413 |
| 62 |
ACUTE INTERSTITIAL PNEUMONITIS |
21 |
0.0402 |
| 63 |
BRONCHOSTENOSIS |
22 |
0.0402 |
| 64 |
GLUCOCORTICOID DEFICIENCY |
17 |
0.0402 |
| 65 |
SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS |
71 |
0.0399 |
| 66 |
RADIATION NECROSIS |
22 |
0.0384 |
| 67 |
IMMUNE-MEDIATED ADVERSE REACTION |
58 |
0.0378 |
| 68 |
BRONCHOPLEURAL FISTULA |
14 |
0.0372 |
| 69 |
RECALL PHENOMENON |
31 |
0.0371 |
| 70 |
STASIS DERMATITIS |
25 |
0.0365 |
| 71 |
HYPOPHYSITIS |
73 |
0.0363 |
| 72 |
SKIN TOXICITY |
203 |
0.0359 |
| 73 |
IMMUNE-MEDIATED HYPOPHYSITIS |
16 |
0.0355 |
| 74 |
METASTASES TO PLEURA |
37 |
0.0353 |
| 75 |
BICYTOPENIA |
69 |
0.0352 |
| 76 |
HAEMATOTOXICITY |
334 |
0.0351 |
| 77 |
METASTASES TO MENINGES |
79 |
0.0347 |
| 78 |
IMMUNE-MEDIATED ENCEPHALITIS |
18 |
0.0340 |
| 79 |
AORTITIS |
23 |
0.0335 |
| 80 |
EXTREMITY NECROSIS |
58 |
0.0332 |
| 81 |
PANCYTOPENIA |
1830 |
0.0327 |
| 82 |
IMMUNE-MEDIATED THYROIDITIS |
16 |
0.0324 |
| 83 |
SYSTEMIC SCLERODERMA |
23 |
0.0316 |
| 84 |
PARONYCHIA |
135 |
0.0307 |
| 85 |
HEPATIC CYTOLYSIS |
391 |
0.0306 |
| 86 |
MALIGNANT NEOPLASM PROGRESSION |
3139 |
0.0306 |
| 87 |
VISCERAL LEISHMANIASIS |
22 |
0.0305 |
| 88 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
46 |
0.0304 |
| 89 |
RENAL TUBULAR NECROSIS |
294 |
0.0299 |
| 90 |
NEUTROPENIC COLITIS |
61 |
0.0295 |
| 91 |
HYPOPITUITARISM |
51 |
0.0293 |
| 92 |
OESOPHAGITIS ULCERATIVE |
20 |
0.0292 |
| 93 |
PNEUMONITIS |
788 |
0.0289 |
| 94 |
THERAPY PARTIAL RESPONDER |
450 |
0.0288 |
| 95 |
GENE MUTATION |
57 |
0.0288 |
| 96 |
TUBULOINTERSTITIAL NEPHRITIS |
534 |
0.0285 |
| 97 |
TRACHEO-OESOPHAGEAL FISTULA |
18 |
0.0282 |
| 98 |
RENAL TUBULAR DISORDER |
79 |
0.0281 |
| 99 |
HYPERAMYLASAEMIA |
15 |
0.0275 |
| 100 |
PULMONARY ARTERY THROMBOSIS |
21 |
0.0273 |
| 101 |
MYELOSUPPRESSION |
958 |
0.0266 |
| 102 |
TUMOUR NECROSIS |
28 |
0.0265 |
| 103 |
HYPERSENSITIVITY PNEUMONITIS |
30 |
0.0263 |
| 104 |
NECROTISING MYOSITIS |
22 |
0.0254 |
| 105 |
BONE MARROW TOXICITY |
29 |
0.0245 |
| 106 |
GASTROINTESTINAL TOXICITY |
117 |
0.0243 |
| 107 |
LUNG CANCER METASTATIC |
69 |
0.0239 |
| 108 |
MUCOSAL INFLAMMATION |
619 |
0.0236 |
| 109 |
NEPHROGENIC DIABETES INSIPIDUS |
27 |
0.0234 |
| 110 |
OTOTOXICITY |
43 |
0.0232 |
| 111 |
SMALL INTESTINAL PERFORATION |
43 |
0.0229 |
| 112 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
290 |
0.0225 |
| 113 |
LYMPHADENOPATHY MEDIASTINAL |
43 |
0.0224 |
| 114 |
HYPERTRANSAMINASAEMIA |
156 |
0.0224 |
| 115 |
ADENOCARCINOMA |
50 |
0.0223 |
| 116 |
BONE MARROW FAILURE |
453 |
0.0223 |
| 117 |
ERYSIPELAS |
111 |
0.0221 |
| 118 |
NEPHROPATHY TOXIC |
240 |
0.0214 |
| 119 |
CARCINOEMBRYONIC ANTIGEN INCREASED |
41 |
0.0211 |
| 120 |
NEUTROPENIC SEPSIS |
151 |
0.0211 |
| 121 |
RADIOTHERAPY |
40 |
0.0209 |
| 122 |
RENAL TUBULAR INJURY |
25 |
0.0206 |
| 123 |
FULMINANT TYPE 1 DIABETES MELLITUS |
21 |
0.0204 |
| 124 |
DUODENAL PERFORATION |
20 |
0.0204 |
| 125 |
PHIMOSIS |
15 |
0.0204 |
| 126 |
LYMPHANGITIS |
16 |
0.0199 |
| 127 |
AORTIC THROMBOSIS |
23 |
0.0199 |
| 128 |
PULMONARY TOXICITY |
140 |
0.0198 |
| 129 |
PERFORMANCE STATUS DECREASED |
91 |
0.0195 |
| 130 |
FEBRILE NEUTROPENIA |
1285 |
0.0194 |
| 131 |
BRONCHIAL CARCINOMA |
15 |
0.0190 |
| 132 |
SUPERINFECTION BACTERIAL |
15 |
0.0189 |
| 133 |
INTERSTITIAL LUNG DISEASE |
913 |
0.0188 |
| 134 |
GRANULOCYTE COUNT DECREASED |
33 |
0.0178 |
| 135 |
DERMATITIS ACNEIFORM |
107 |
0.0176 |
| 136 |
LUNG CONSOLIDATION |
49 |
0.0175 |
| 137 |
ENTERITIS |
111 |
0.0173 |
| 138 |
ANAL ULCER |
14 |
0.0171 |
| 139 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
125 |
0.0166 |
| 140 |
EMBOLISM ARTERIAL |
20 |
0.0166 |
| 141 |
NEOPLASM PROGRESSION |
579 |
0.0166 |
| 142 |
SUPERFICIAL VEIN THROMBOSIS |
14 |
0.0166 |
| 143 |
HYPOALBUMINAEMIA |
128 |
0.0164 |
| 144 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
18 |
0.0164 |
| 145 |
LARGE INTESTINE INFECTION |
20 |
0.0163 |
| 146 |
PERIPHERAL ISCHAEMIA |
66 |
0.0161 |
| 147 |
MYOCARDITIS |
184 |
0.0160 |
| 148 |
SMALL CELL LUNG CANCER |
24 |
0.0159 |
| 149 |
PLEURAL FIBROSIS |
16 |
0.0157 |
| 150 |
KIDNEY FIBROSIS |
27 |
0.0156 |
| 151 |
HEPATOCELLULAR INJURY |
219 |
0.0154 |
| 152 |
OCULAR TOXICITY |
17 |
0.0154 |
| 153 |
HYPERTHYROIDISM |
223 |
0.0154 |
| 154 |
OESOPHAGITIS |
166 |
0.0152 |
| 155 |
EMBOLISM VENOUS |
46 |
0.0152 |
| 156 |
ADRENAL DISORDER |
29 |
0.0151 |
| 157 |
THROMBOCYTOPENIA |
1675 |
0.0150 |
| 158 |
MIXED LIVER INJURY |
45 |
0.0149 |
| 159 |
CANCER PAIN |
38 |
0.0148 |
| 160 |
ENTEROCOLITIS |
85 |
0.0147 |
| 161 |
CHOLANGITIS |
91 |
0.0147 |
| 162 |
ADRENAL INSUFFICIENCY |
178 |
0.0147 |
| 163 |
DIVERTICULAR PERFORATION |
30 |
0.0146 |
| 164 |
SYSTEMIC INFECTION |
24 |
0.0145 |
| 165 |
CAPILLARY LEAK SYNDROME |
29 |
0.0140 |
| 166 |
GASTROINTESTINAL PERFORATION |
58 |
0.0139 |
| 167 |
PALMAR ERYTHEMA |
16 |
0.0139 |
| 168 |
RASH MACULO-PAPULAR |
309 |
0.0139 |
| 169 |
CREATININE RENAL CLEARANCE DECREASED |
54 |
0.0135 |
| 170 |
MAGNETIC RESONANCE IMAGING ABNORMAL |
16 |
0.0134 |
| 171 |
NEUTROPHIL COUNT DECREASED |
541 |
0.0133 |
| 172 |
COLITIS |
502 |
0.0132 |
| 173 |
SUBCLAVIAN VEIN THROMBOSIS |
15 |
0.0132 |
| 174 |
NEUTROPENIA |
1792 |
0.0132 |
| 175 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
20 |
0.0131 |
| 176 |
VENOUS THROMBOSIS |
51 |
0.0130 |
| 177 |
PRERENAL FAILURE |
18 |
0.0128 |
| 178 |
FEBRILE INFECTION |
15 |
0.0127 |
| 179 |
DERMATITIS BULLOUS |
92 |
0.0127 |
| 180 |
CHOLANGITIS SCLEROSING |
26 |
0.0126 |
| 181 |
LEUKOPENIA |
633 |
0.0126 |
| 182 |
TROPONIN T INCREASED |
16 |
0.0126 |
| 183 |
NEPHROSCLEROSIS |
14 |
0.0126 |
| 184 |
DRUG RESISTANCE |
322 |
0.0125 |
| 185 |
MYOCARDIAL INJURY |
14 |
0.0124 |
| 186 |
LARGE INTESTINE PERFORATION |
86 |
0.0124 |
| 187 |
MESOTHELIOMA |
16 |
0.0123 |
| 188 |
THYROIDITIS |
37 |
0.0123 |
| 189 |
METASTASES TO PERITONEUM |
31 |
0.0123 |
| 190 |
HEPATOTOXICITY |
273 |
0.0122 |
| 191 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
42 |
0.0122 |
| 192 |
ENCEPHALITIS AUTOIMMUNE |
16 |
0.0122 |
| 193 |
TUMOUR PAIN |
16 |
0.0121 |
| 194 |
BRONCHIAL OBSTRUCTION |
17 |
0.0121 |
| 195 |
DERMATITIS EXFOLIATIVE GENERALISED |
42 |
0.0121 |
| 196 |
DISEASE PROGRESSION |
1427 |
0.0120 |
| 197 |
VENA CAVA THROMBOSIS |
20 |
0.0120 |
| 198 |
HYPOTHYROIDISM |
384 |
0.0120 |
| 199 |
TOXIC SKIN ERUPTION |
120 |
0.0119 |
| 200 |
ALANINE AMINOTRANSFERASE ABNORMAL |
25 |
0.0118 |
| 201 |
CUTANEOUS LUPUS ERYTHEMATOSUS |
23 |
0.0118 |
| 202 |
IMMUNE THROMBOCYTOPENIA |
54 |
0.0118 |
| 203 |
DUODENITIS |
36 |
0.0117 |
| 204 |
HAEMOPTYSIS |
326 |
0.0117 |
| 205 |
HYPOTHALAMO-PITUITARY DISORDER |
17 |
0.0117 |
| 206 |
HEPATITIS TOXIC |
30 |
0.0115 |
| 207 |
MONOCYTE COUNT DECREASED |
14 |
0.0115 |
| 208 |
PLEURAL EFFUSION |
696 |
0.0114 |
| 209 |
ANAEMIA |
2178 |
0.0114 |
| 210 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
16 |
0.0114 |
| 211 |
LUNG OPACITY |
30 |
0.0114 |
| 212 |
HEPATITIS |
291 |
0.0114 |
| 213 |
TOXIC EPIDERMAL NECROLYSIS |
171 |
0.0112 |
| 214 |
IMMUNE-MEDIATED MYOSITIS |
31 |
0.0112 |
| 215 |
DIABETES INSIPIDUS |
27 |
0.0112 |
| 216 |
PURPURA |
99 |
0.0112 |
| 217 |
KERATITIS |
34 |
0.0112 |
| 218 |
VENOUS THROMBOSIS LIMB |
23 |
0.0111 |
| 219 |
PULMONARY SEPSIS |
16 |
0.0110 |
| 220 |
AUTOIMMUNE HEPATITIS |
76 |
0.0109 |
| 221 |
BLOOD CHLORIDE DECREASED |
28 |
0.0108 |
| 222 |
METASTASES TO LYMPH NODES |
73 |
0.0108 |
| 223 |
HYPOMAGNESAEMIA |
150 |
0.0108 |
| 224 |
PERIPHERAL MOTOR NEUROPATHY |
15 |
0.0107 |
| 225 |
TYPE 1 DIABETES MELLITUS |
64 |
0.0106 |
| 226 |
ORAL FUNGAL INFECTION |
29 |
0.0106 |
| 227 |
METASTASES TO LUNG |
122 |
0.0105 |
| 228 |
HYPOPROTEINAEMIA |
20 |
0.0105 |
| 229 |
STAPHYLOCOCCUS TEST POSITIVE |
22 |
0.0104 |
| 230 |
NON-CARDIAC CHEST PAIN |
33 |
0.0104 |
| 231 |
METASTASES TO BONE |
171 |
0.0104 |
| 232 |
PERIORBITAL OEDEMA |
54 |
0.0104 |
| 233 |
ARTERIAL THROMBOSIS |
20 |
0.0103 |
| 234 |
SPLENIC INFARCTION |
18 |
0.0103 |
| 235 |
MULTIPLE-DRUG RESISTANCE |
32 |
0.0103 |
| 236 |
CARDIAC TAMPONADE |
49 |
0.0103 |
| 237 |
ANAEMIA MACROCYTIC |
22 |
0.0103 |
| 238 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
20 |
0.0102 |
| 239 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
39 |
0.0102 |
| 240 |
PERICARDIAL EFFUSION |
236 |
0.0102 |
| 241 |
SEPTIC SHOCK |
443 |
0.0102 |
| 242 |
HICCUPS |
83 |
0.0101 |
| 243 |
ORGANISING PNEUMONIA |
50 |
0.0101 |
| 244 |
PROTEINURIA |
190 |
0.0100 |
| 245 |
ALVEOLITIS |
14 |
0.0099 |
| 246 |
NEUTROPHIL COUNT ABNORMAL |
28 |
0.0099 |
| 247 |
PNEUMOPERITONEUM |
18 |
0.0097 |
| 248 |
ATELECTASIS |
94 |
0.0097 |
| 249 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
34 |
0.0096 |
| 250 |
PNEUMOTHORAX |
153 |
0.0096 |
| 251 |
CYTOPENIA |
118 |
0.0096 |
| 252 |
CHOLESTASIS |
185 |
0.0096 |
| 253 |
GASTROINTESTINAL NECROSIS |
28 |
0.0096 |
| 254 |
HYPOCALCAEMIA |
181 |
0.0096 |
| 255 |
PANNICULITIS |
23 |
0.0095 |
| 256 |
HYPERPYREXIA |
40 |
0.0094 |
| 257 |
LEUKOENCEPHALOPATHY |
35 |
0.0094 |
| 258 |
METASTASES TO LIVER |
165 |
0.0094 |
| 259 |
METASTASIS |
67 |
0.0094 |
| 260 |
HAEMOTHORAX |
27 |
0.0093 |
| 261 |
HEPATITIS CHOLESTATIC |
56 |
0.0093 |
| 262 |
PERIPHERAL SENSORY NEUROPATHY |
54 |
0.0092 |
| 263 |
MYOSITIS |
82 |
0.0091 |
| 264 |
EMBOLISM |
75 |
0.0090 |
| 265 |
ESCHERICHIA BACTERAEMIA |
21 |
0.0089 |
| 266 |
ISCHAEMIA |
41 |
0.0089 |
| 267 |
DISSEMINATED INTRAVASCULAR COAGULATION |
124 |
0.0088 |
| 268 |
POLYARTHRITIS |
46 |
0.0087 |
| 269 |
ACUTE KIDNEY INJURY |
1335 |
0.0087 |
| 270 |
ENCEPHALITIS |
60 |
0.0087 |
| 271 |
LUNG INFILTRATION |
76 |
0.0086 |
| 272 |
HEPATIC FUNCTION ABNORMAL |
321 |
0.0086 |
| 273 |
TRANSAMINASES INCREASED |
191 |
0.0086 |
| 274 |
ACUTE CORONARY SYNDROME |
70 |
0.0084 |
| 275 |
GENERAL PHYSICAL HEALTH DETERIORATION |
977 |
0.0084 |
| 276 |
PNEUMATOSIS INTESTINALIS |
24 |
0.0084 |
| 277 |
DUODENAL ULCER HAEMORRHAGE |
24 |
0.0084 |
| 278 |
CACHEXIA |
43 |
0.0083 |
| 279 |
ESCHERICHIA SEPSIS |
24 |
0.0083 |
| 280 |
OESOPHAGEAL CANDIDIASIS |
33 |
0.0083 |
| 281 |
SCLERODERMA |
30 |
0.0082 |
| 282 |
METASTATIC NEOPLASM |
35 |
0.0081 |
| 283 |
BLOOD ALBUMIN DECREASED |
64 |
0.0081 |
| 284 |
EMPYEMA |
16 |
0.0080 |
| 285 |
HAEMOLYTIC ANAEMIA |
72 |
0.0080 |
| 286 |
OPTIC NEUROPATHY |
17 |
0.0080 |
| 287 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
76 |
0.0080 |
| 288 |
HYPOKALAEMIA |
366 |
0.0079 |
| 289 |
INTESTINAL PERFORATION |
89 |
0.0079 |
| 290 |
PNEUMONIA BACTERIAL |
72 |
0.0078 |
| 291 |
CHEST X-RAY ABNORMAL |
24 |
0.0078 |
| 292 |
RESPIRATORY FAILURE |
569 |
0.0078 |
| 293 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
78 |
0.0078 |
| 294 |
BONE LESION |
28 |
0.0078 |
| 295 |
VITILIGO |
18 |
0.0077 |
| 296 |
PULMONARY HAEMORRHAGE |
60 |
0.0077 |
| 297 |
INFLAMMATORY MARKER INCREASED |
38 |
0.0077 |
| 298 |
INTESTINAL ISCHAEMIA |
42 |
0.0076 |
| 299 |
CELL DEATH |
15 |
0.0076 |
| 300 |
ISCHAEMIC STROKE |
134 |
0.0075 |
| 301 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
34 |
0.0075 |
| 302 |
AGRANULOCYTOSIS |
139 |
0.0075 |
| 303 |
RENAL IMPAIRMENT |
628 |
0.0075 |
| 304 |
MUCOSAL DRYNESS |
15 |
0.0074 |
| 305 |
METASTASES TO SPINE |
25 |
0.0074 |
| 306 |
PLATELET COUNT DECREASED |
788 |
0.0074 |
| 307 |
NEOPLASM RECURRENCE |
25 |
0.0074 |
| 308 |
BLOOD CREATININE INCREASED |
477 |
0.0073 |
| 309 |
RHEUMATOID NODULE |
20 |
0.0073 |
| 310 |
SUBILEUS |
15 |
0.0072 |
| 311 |
DYSAESTHESIA |
22 |
0.0072 |
| 312 |
ACUTE RESPIRATORY FAILURE |
138 |
0.0072 |
| 313 |
APLASTIC ANAEMIA |
37 |
0.0071 |
| 314 |
SUSPECTED OFF LABEL USE |
32 |
0.0071 |
| 315 |
PULMONARY EMBOLISM |
665 |
0.0070 |
| 316 |
HYPERPHOSPHATAEMIA |
15 |
0.0070 |
| 317 |
APLASIA PURE RED CELL |
24 |
0.0070 |
| 318 |
POLYNEUROPATHY |
83 |
0.0069 |
| 319 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
153 |
0.0069 |
| 320 |
METABOLIC DISORDER |
40 |
0.0069 |
| 321 |
ERYTHEMA MULTIFORME |
64 |
0.0069 |
| 322 |
CARDIOTOXICITY |
61 |
0.0068 |
| 323 |
IDIOPATHIC PULMONARY FIBROSIS |
27 |
0.0068 |
| 324 |
COLITIS ISCHAEMIC |
46 |
0.0068 |
| 325 |
HYPERURICAEMIA |
28 |
0.0068 |
| 326 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
21 |
0.0068 |
| 327 |
HEPATITIS ACUTE |
44 |
0.0068 |
| 328 |
CHOLESTATIC LIVER INJURY |
15 |
0.0067 |
| 329 |
C-REACTIVE PROTEIN INCREASED |
245 |
0.0067 |
| 330 |
DRUG ERUPTION |
119 |
0.0067 |
| 331 |
OESOPHAGEAL STENOSIS |
19 |
0.0067 |
| 332 |
CYTOKINE RELEASE SYNDROME |
134 |
0.0067 |
| 333 |
POLYMYALGIA RHEUMATICA |
21 |
0.0066 |
| 334 |
VASCULITIS |
77 |
0.0066 |
| 335 |
APHTHOUS ULCER |
51 |
0.0066 |
| 336 |
LEFT VENTRICULAR DYSFUNCTION |
44 |
0.0066 |
| 337 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
51 |
0.0066 |
| 338 |
STOMATITIS |
395 |
0.0065 |
| 339 |
GRANULOCYTOPENIA |
37 |
0.0065 |
| 340 |
RASH MORBILLIFORM |
18 |
0.0065 |
| 341 |
TROPONIN INCREASED |
49 |
0.0064 |
| 342 |
ASPARTATE AMINOTRANSFERASE INCREASED |
342 |
0.0064 |
| 343 |
PROCTITIS |
18 |
0.0064 |
| 344 |
NEPHROTIC SYNDROME |
44 |
0.0064 |
| 345 |
ILEUS |
79 |
0.0064 |
| 346 |
URINARY TRACT OBSTRUCTION |
15 |
0.0063 |
| 347 |
TUMOUR HAEMORRHAGE |
18 |
0.0063 |
| 348 |
STAPHYLOCOCCAL SEPSIS |
31 |
0.0063 |
| 349 |
PHLEBITIS |
32 |
0.0062 |
| 350 |
RASH PUSTULAR |
45 |
0.0062 |
| 351 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
109 |
0.0062 |
| 352 |
PATHOLOGICAL FRACTURE |
31 |
0.0061 |
| 353 |
BLOOD CREATINE INCREASED |
27 |
0.0061 |
| 354 |
LICHEN PLANUS |
14 |
0.0060 |
| 355 |
CYTOLYTIC HEPATITIS |
20 |
0.0060 |
| 356 |
OSTEONECROSIS OF JAW |
149 |
0.0060 |
| 357 |
IMMUNE THROMBOCYTOPENIC PURPURA |
17 |
0.0060 |
| 358 |
DERMATITIS EXFOLIATIVE |
30 |
0.0060 |
| 359 |
BONE MARROW DISORDER |
18 |
0.0060 |
| 360 |
SUDDEN DEATH |
63 |
0.0059 |
| 361 |
HYPONATRAEMIA |
335 |
0.0059 |
| 362 |
CUSHINGOID |
19 |
0.0059 |
| 363 |
SEPSIS |
656 |
0.0059 |
| 364 |
HYPOVOLAEMIC SHOCK |
28 |
0.0058 |
| 365 |
PLEURITIC PAIN |
16 |
0.0058 |
| 366 |
ALANINE AMINOTRANSFERASE INCREASED |
351 |
0.0057 |
| 367 |
SKIN HYPERPIGMENTATION |
49 |
0.0057 |
| 368 |
AMYLASE INCREASED |
21 |
0.0057 |
| 369 |
RENAL FAILURE |
755 |
0.0057 |
| 370 |
WHITE BLOOD CELL COUNT DECREASED |
611 |
0.0056 |
| 371 |
ORAL CANDIDIASIS |
74 |
0.0056 |
| 372 |
SMALL INTESTINAL OBSTRUCTION |
69 |
0.0056 |
| 373 |
ILEUS PARALYTIC |
25 |
0.0056 |
| 374 |
ANAPHYLACTOID REACTION |
23 |
0.0056 |
| 375 |
RASH VESICULAR |
27 |
0.0056 |
| 376 |
PROTEIN TOTAL DECREASED |
21 |
0.0056 |
| 377 |
HEPATIC LESION |
24 |
0.0055 |
| 378 |
PULMONARY FIBROSIS |
106 |
0.0055 |
| 379 |
DYSPNOEA AT REST |
16 |
0.0055 |
| 380 |
ATRIAL FLUTTER |
44 |
0.0055 |
| 381 |
CUTANEOUS VASCULITIS |
20 |
0.0055 |
| 382 |
DRUG-INDUCED LIVER INJURY |
171 |
0.0054 |
| 383 |
CEREBRAL ISCHAEMIA |
28 |
0.0054 |
| 384 |
THORACIC VERTEBRAL FRACTURE |
16 |
0.0054 |
| 385 |
VENTRICULAR DYSFUNCTION |
14 |
0.0054 |
| 386 |
BLOOD UREA INCREASED |
90 |
0.0054 |
| 387 |
ASCITES |
157 |
0.0053 |
| 388 |
EXFOLIATIVE RASH |
14 |
0.0053 |
| 389 |
MALNUTRITION |
59 |
0.0053 |
| 390 |
MOUTH ULCERATION |
110 |
0.0052 |
| 391 |
LIP OEDEMA |
22 |
0.0052 |
| 392 |
THROMBOCYTOSIS |
19 |
0.0052 |
| 393 |
ELECTROLYTE IMBALANCE |
60 |
0.0052 |
| 394 |
GENERAL PHYSICAL CONDITION ABNORMAL |
35 |
0.0052 |
| 395 |
INFUSION RELATED REACTION |
342 |
0.0052 |
| 396 |
SPINAL CORD COMPRESSION |
20 |
0.0051 |
| 397 |
PERITONITIS |
106 |
0.0051 |
| 398 |
CLONUS |
14 |
0.0051 |
| 399 |
HYPOXIA |
180 |
0.0051 |
| 400 |
BLOOD CREATININE DECREASED |
16 |
0.0051 |
| 401 |
HYPERTHERMIA |
39 |
0.0051 |
| 402 |
RETINOPATHY |
19 |
0.0051 |
| 403 |
FIBRIN D DIMER INCREASED |
18 |
0.0051 |
| 404 |
PLEURISY |
30 |
0.0050 |
| 405 |
SECOND PRIMARY MALIGNANCY |
42 |
0.0050 |
| 406 |
HAEMATOCRIT DECREASED |
100 |
0.0050 |
| 407 |
PEMPHIGOID |
38 |
0.0050 |
| 408 |
DIVERTICULUM INTESTINAL |
22 |
0.0050 |
| 409 |
ODYNOPHAGIA |
30 |
0.0050 |
| 410 |
BLOOD CULTURE POSITIVE |
15 |
0.0050 |
| 411 |
FAILURE TO THRIVE |
26 |
0.0050 |
| 412 |
RENAL FAILURE ACUTE |
212 |
0.0050 |
| 413 |
ARTERIOSCLEROSIS |
47 |
0.0050 |
| 414 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
15 |
0.0050 |
| 415 |
ACUTE PULMONARY OEDEMA |
28 |
0.0050 |
| 416 |
DRUG TOLERANCE DECREASED |
14 |
0.0050 |
| 417 |
ARTERIOSPASM CORONARY |
20 |
0.0050 |
| 418 |
BLOOD MAGNESIUM DECREASED |
43 |
0.0050 |
| 419 |
DUODENAL ULCER |
35 |
0.0050 |
| 420 |
RENAL FUNCTION TEST ABNORMAL |
23 |
0.0049 |
| 421 |
DEHYDRATION |
658 |
0.0049 |
| 422 |
RESPIRATORY DISTRESS |
135 |
0.0049 |
| 423 |
TEARFULNESS |
21 |
0.0049 |
| 424 |
HYPOPHOSPHATAEMIA |
36 |
0.0049 |
| 425 |
FACE OEDEMA |
82 |
0.0049 |
| 426 |
PERICARDITIS |
81 |
0.0048 |
| 427 |
FLUID INTAKE REDUCED |
24 |
0.0048 |
| 428 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
76 |
0.0048 |
| 429 |
LIVER INJURY |
117 |
0.0048 |
| 430 |
DECREASED APPETITE |
1106 |
0.0048 |
| 431 |
LOCALISED OEDEMA |
22 |
0.0047 |
| 432 |
BRAIN OEDEMA |
60 |
0.0047 |
| 433 |
MULTI-ORGAN FAILURE |
82 |
0.0047 |
| 434 |
STEVENS-JOHNSON SYNDROME |
105 |
0.0047 |
| 435 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
117 |
0.0047 |
| 436 |
CEREBRAL INFARCTION |
115 |
0.0047 |
| 437 |
PETECHIAE |
49 |
0.0047 |
| 438 |
EPISTAXIS |
350 |
0.0047 |
| 439 |
COMPRESSION FRACTURE |
25 |
0.0047 |
| 440 |
LYMPHOCYTE COUNT DECREASED |
82 |
0.0046 |
| 441 |
DERMATITIS |
97 |
0.0046 |
| 442 |
EPIGASTRIC DISCOMFORT |
18 |
0.0046 |
| 443 |
NEUTROPHILIA |
26 |
0.0046 |
| 444 |
THROMBOPHLEBITIS |
16 |
0.0046 |
| 445 |
FIBROSIS |
14 |
0.0045 |
| 446 |
GUILLAIN-BARRE SYNDROME |
22 |
0.0045 |
| 447 |
GASTRIC ULCER HAEMORRHAGE |
25 |
0.0045 |
| 448 |
ANOREXIA |
58 |
0.0045 |
| 449 |
NECROSIS |
25 |
0.0045 |
| 450 |
LUNG DISORDER |
220 |
0.0045 |
| 451 |
ANAPHYLACTIC SHOCK |
115 |
0.0045 |
| 452 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
41 |
0.0045 |
| 453 |
HYPOVOLAEMIA |
26 |
0.0044 |
| 454 |
HYPOPHAGIA |
113 |
0.0044 |
| 455 |
HEPATIC CYST |
15 |
0.0044 |
| 456 |
HYPERNATRAEMIA |
22 |
0.0044 |
| 457 |
THROMBOTIC MICROANGIOPATHY |
43 |
0.0044 |
| 458 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
18 |
0.0044 |
| 459 |
CIRCULATORY COLLAPSE |
75 |
0.0044 |
| 460 |
DEEP VEIN THROMBOSIS |
286 |
0.0044 |
| 461 |
NEPHROPATHY |
41 |
0.0044 |
| 462 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
45 |
0.0044 |
| 463 |
LUMBAR VERTEBRAL FRACTURE |
20 |
0.0044 |
| 464 |
BLOOD SODIUM DECREASED |
82 |
0.0043 |
| 465 |
SKIN EROSION |
14 |
0.0043 |
| 466 |
HERPES VIRUS INFECTION |
25 |
0.0043 |
| 467 |
CARDIOMYOPATHY |
64 |
0.0043 |
| 468 |
SUPRAVENTRICULAR TACHYCARDIA |
41 |
0.0043 |
| 469 |
PULMONARY ALVEOLAR HAEMORRHAGE |
24 |
0.0043 |
| 470 |
EMPHYSEMA |
43 |
0.0043 |
| 471 |
OEDEMA |
230 |
0.0042 |
| 472 |
LUNG NEOPLASM |
18 |
0.0042 |
| 473 |
MYASTHENIA GRAVIS |
34 |
0.0042 |
| 474 |
FAECALOMA |
23 |
0.0042 |
| 475 |
ACUTE MYELOID LEUKAEMIA |
65 |
0.0042 |
| 476 |
TONGUE ULCERATION |
14 |
0.0041 |
| 477 |
OPTIC ISCHAEMIC NEUROPATHY |
16 |
0.0041 |
| 478 |
CARDIOGENIC SHOCK |
59 |
0.0041 |
| 479 |
PULMONARY MASS |
61 |
0.0041 |
| 480 |
BLOOD CALCIUM DECREASED |
46 |
0.0041 |
| 481 |
BRONCHOPNEUMONIA |
14 |
0.0041 |
| 482 |
BREATH SOUNDS ABNORMAL |
20 |
0.0041 |
| 483 |
LYMPHOEDEMA |
28 |
0.0040 |
| 484 |
MENINGITIS |
27 |
0.0040 |
| 485 |
HAEMOGLOBIN DECREASED |
415 |
0.0040 |
| 486 |
HYPERKALAEMIA |
141 |
0.0040 |
| 487 |
DYSPNOEA EXERTIONAL |
151 |
0.0040 |
| 488 |
BLOOD BILIRUBIN INCREASED |
108 |
0.0040 |
| 489 |
CONJUNCTIVITIS |
74 |
0.0040 |
| 490 |
PAPILLOEDEMA |
18 |
0.0040 |
| 491 |
PNEUMONIA |
1288 |
0.0040 |
| 492 |
SKIN REACTION |
56 |
0.0040 |
| 493 |
FLANK PAIN |
37 |
0.0039 |
| 494 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
111 |
0.0039 |
| 495 |
NEUTROPHIL COUNT INCREASED |
40 |
0.0039 |
| 496 |
OEDEMA PERIPHERAL |
476 |
0.0039 |
| 497 |
OESOPHAGEAL ULCER |
15 |
0.0039 |
| 498 |
ENDOCARDITIS |
20 |
0.0039 |
| 499 |
LUNG NEOPLASM MALIGNANT |
157 |
0.0038 |
| 500 |
BLOOD URIC ACID INCREASED |
22 |
0.0038 |
| 501 |
PYREXIA |
1315 |
0.0038 |
| 502 |
MENINGITIS ASEPTIC |
17 |
0.0038 |
| 503 |
MUSCLE FATIGUE |
16 |
0.0038 |
| 504 |
DIARRHOEA HAEMORRHAGIC |
35 |
0.0037 |
| 505 |
BRONCHOPULMONARY ASPERGILLOSIS |
29 |
0.0037 |
| 506 |
CANDIDIASIS |
15 |
0.0037 |
| 507 |
LUNG INFECTION |
58 |
0.0037 |
| 508 |
RECURRENT CANCER |
15 |
0.0037 |
| 509 |
LIVER DISORDER |
163 |
0.0037 |
| 510 |
GENERALISED OEDEMA |
45 |
0.0036 |
| 511 |
HEPATIC FAILURE |
109 |
0.0036 |
| 512 |
CHOLECYSTITIS |
43 |
0.0036 |
| 513 |
RESPIRATORY TRACT INFECTION |
94 |
0.0036 |
| 514 |
HYDRONEPHROSIS |
27 |
0.0036 |
| 515 |
PANCREATITIS ACUTE |
81 |
0.0036 |
| 516 |
CARDIAC FAILURE ACUTE |
24 |
0.0036 |
| 517 |
RED BLOOD CELL COUNT DECREASED |
103 |
0.0036 |
| 518 |
ACUTE MYOCARDIAL INFARCTION |
106 |
0.0036 |
| 519 |
SARCOIDOSIS |
17 |
0.0036 |
| 520 |
HAEMOGLOBIN ABNORMAL |
23 |
0.0036 |
| 521 |
LACRIMATION INCREASED |
108 |
0.0036 |
| 522 |
SHOCK HAEMORRHAGIC |
29 |
0.0036 |
| 523 |
ATRIAL FIBRILLATION |
345 |
0.0035 |
| 524 |
LEUKOCYTOSIS |
64 |
0.0035 |
| 525 |
EYELID OEDEMA |
41 |
0.0035 |
| 526 |
PROTHROMBIN TIME PROLONGED |
21 |
0.0035 |
| 527 |
SKIN DISORDER |
117 |
0.0035 |
| 528 |
NEUROLOGICAL SYMPTOM |
20 |
0.0035 |
| 529 |
MELAENA |
77 |
0.0035 |
| 530 |
PLATELET COUNT ABNORMAL |
21 |
0.0035 |
| 531 |
STAPHYLOCOCCAL BACTERAEMIA |
15 |
0.0034 |
| 532 |
HOSPICE CARE |
34 |
0.0034 |
| 533 |
STRESS CARDIOMYOPATHY |
20 |
0.0034 |
| 534 |
POLYURIA |
28 |
0.0034 |
| 535 |
LUPUS-LIKE SYNDROME |
31 |
0.0034 |
| 536 |
EXTRAVASATION |
14 |
0.0034 |
| 537 |
PIGMENTATION DISORDER |
21 |
0.0034 |
| 538 |
PLATELET COUNT INCREASED |
44 |
0.0034 |
| 539 |
PNEUMONIA ASPIRATION |
83 |
0.0033 |
| 540 |
NEUROPATHY PERIPHERAL |
312 |
0.0033 |
| 541 |
ASTHENIA |
1228 |
0.0033 |
| 542 |
MYOCARDIAL ISCHAEMIA |
37 |
0.0032 |
| 543 |
CELLULITIS |
162 |
0.0032 |
| 544 |
DIVERTICULITIS |
89 |
0.0032 |
| 545 |
GASTRITIS |
84 |
0.0032 |
| 546 |
WHITE BLOOD CELL COUNT ABNORMAL |
20 |
0.0031 |
| 547 |
LYMPHOPENIA |
44 |
0.0031 |
| 548 |
VOMITING |
1461 |
0.0031 |
| 549 |
SINUS TACHYCARDIA |
44 |
0.0031 |
| 550 |
TRISMUS |
16 |
0.0031 |
| 551 |
NEUROTOXICITY |
54 |
0.0031 |
| 552 |
RASH |
1334 |
0.0031 |
| 553 |
CARDIAC FAILURE |
244 |
0.0030 |
| 554 |
EOSINOPHILIA |
53 |
0.0030 |
| 555 |
EJECTION FRACTION DECREASED |
47 |
0.0030 |
| 556 |
CLOSTRIDIUM DIFFICILE COLITIS |
32 |
0.0030 |
| 557 |
HEMIPLEGIA |
25 |
0.0030 |
| 558 |
SKIN ABRASION |
14 |
0.0030 |
| 559 |
DYSPHAGIA |
281 |
0.0030 |
| 560 |
CONSTIPATION |
638 |
0.0029 |
| 561 |
DIARRHOEA |
1883 |
0.0029 |
| 562 |
HYPERCALCAEMIA |
36 |
0.0029 |
| 563 |
OLIGURIA |
18 |
0.0029 |
| 564 |
HAEMODYNAMIC INSTABILITY |
22 |
0.0029 |
| 565 |
VENTRICULAR FIBRILLATION |
32 |
0.0029 |
| 566 |
HAEMATEMESIS |
73 |
0.0029 |
| 567 |
BRONCHOSPASM |
41 |
0.0029 |
| 568 |
LIPASE INCREASED |
22 |
0.0029 |
| 569 |
FOLLICULITIS |
30 |
0.0029 |
| 570 |
THYROID DISORDER |
44 |
0.0029 |
| 571 |
CARDIO-RESPIRATORY ARREST |
119 |
0.0028 |
| 572 |
SPINAL OSTEOARTHRITIS |
25 |
0.0028 |
| 573 |
ANAPHYLACTIC REACTION |
157 |
0.0028 |
| 574 |
PANCREATIC DISORDER |
14 |
0.0028 |
| 575 |
GASTRIC ULCER |
54 |
0.0028 |
| 576 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
21 |
0.0028 |
| 577 |
CHOLECYSTITIS ACUTE |
16 |
0.0028 |
| 578 |
RASH PRURITIC |
153 |
0.0028 |
| 579 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
200 |
0.0028 |
| 580 |
GASTROINTESTINAL INFLAMMATION |
22 |
0.0028 |
| 581 |
PROTEIN URINE PRESENT |
14 |
0.0028 |
| 582 |
ARTERIAL OCCLUSIVE DISEASE |
22 |
0.0028 |
| 583 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
65 |
0.0028 |
| 584 |
GINGIVITIS |
15 |
0.0028 |
| 585 |
MENTAL STATUS CHANGES |
77 |
0.0028 |
| 586 |
CHEILITIS |
15 |
0.0028 |
| 587 |
ENCEPHALOPATHY |
68 |
0.0028 |
| 588 |
SQUAMOUS CELL CARCINOMA |
26 |
0.0028 |
| 589 |
SUBARACHNOID HAEMORRHAGE |
28 |
0.0027 |
| 590 |
LIVER FUNCTION TEST INCREASED |
59 |
0.0027 |
| 591 |
BLOOD DISORDER |
22 |
0.0027 |
| 592 |
CYANOSIS |
43 |
0.0027 |
| 593 |
MOUTH HAEMORRHAGE |
20 |
0.0027 |
| 594 |
VENTRICULAR TACHYCARDIA |
45 |
0.0027 |
| 595 |
WHITE BLOOD CELL COUNT INCREASED |
104 |
0.0027 |
| 596 |
GINGIVAL BLEEDING |
37 |
0.0027 |
| 597 |
NEOPLASM |
31 |
0.0027 |
| 598 |
BACTERAEMIA |
32 |
0.0027 |
| 599 |
ATAXIA |
32 |
0.0027 |
| 600 |
VENTRICULAR EXTRASYSTOLES |
28 |
0.0027 |
| 601 |
OFF LABEL USE |
2360 |
0.0027 |
| 602 |
ANGIOPATHY |
15 |
0.0027 |
| 603 |
EYELID PTOSIS |
27 |
0.0027 |
| 604 |
DRUG TOXICITY |
36 |
0.0026 |
| 605 |
GENERALISED ERYTHEMA |
15 |
0.0026 |
| 606 |
HYPERGLYCAEMIA |
95 |
0.0026 |
| 607 |
HYPERBILIRUBINAEMIA |
27 |
0.0026 |
| 608 |
REFUSAL OF TREATMENT BY PATIENT |
17 |
0.0026 |
| 609 |
LYMPHADENOPATHY |
92 |
0.0026 |
| 610 |
OXYGEN SATURATION DECREASED |
146 |
0.0026 |
| 611 |
LARYNGEAL OEDEMA |
16 |
0.0026 |
| 612 |
MUSCULOSKELETAL CHEST PAIN |
40 |
0.0026 |
| 613 |
LIVER FUNCTION TEST ABNORMAL |
75 |
0.0026 |
| 614 |
HYDROCEPHALUS |
14 |
0.0026 |
| 615 |
ARTERIOSCLEROSIS CORONARY ARTERY |
17 |
0.0026 |
| 616 |
ADVERSE REACTION |
34 |
0.0026 |
| 617 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
43 |
0.0026 |
| 618 |
GASTROENTERITIS |
37 |
0.0025 |
| 619 |
ORTHOSTATIC HYPOTENSION |
44 |
0.0025 |
| 620 |
RENAL CYST |
20 |
0.0025 |
| 621 |
TACHYPNOEA |
34 |
0.0025 |
| 622 |
DIABETIC KETOACIDOSIS |
60 |
0.0025 |
| 623 |
SKIN INFECTION |
28 |
0.0025 |
| 624 |
NAUSEA |
1967 |
0.0025 |
| 625 |
DELIRIUM |
86 |
0.0025 |
| 626 |
COVID-19 PNEUMONIA |
29 |
0.0025 |
| 627 |
DECUBITUS ULCER |
20 |
0.0025 |
| 628 |
EPILEPSY |
75 |
0.0025 |
| 629 |
TACHYCARDIA |
217 |
0.0024 |
| 630 |
HEPATOMEGALY |
24 |
0.0024 |
| 631 |
ASPERGILLUS INFECTION |
16 |
0.0024 |
| 632 |
SHOCK |
56 |
0.0024 |
| 633 |
DYSPNOEA |
1367 |
0.0024 |
| 634 |
ATRIOVENTRICULAR BLOCK COMPLETE |
16 |
0.0024 |
| 635 |
RESPIRATORY RATE INCREASED |
21 |
0.0024 |
| 636 |
ACUTE HEPATIC FAILURE |
32 |
0.0023 |
| 637 |
RENAL DISORDER |
109 |
0.0023 |
| 638 |
PROCTALGIA |
15 |
0.0023 |
| 639 |
INFECTION |
336 |
0.0023 |
| 640 |
RIGHT VENTRICULAR FAILURE |
16 |
0.0023 |
| 641 |
GLOMERULAR FILTRATION RATE DECREASED |
28 |
0.0023 |
| 642 |
CANDIDA INFECTION |
38 |
0.0022 |
| 643 |
BRONCHIECTASIS |
15 |
0.0022 |
| 644 |
ACIDOSIS |
17 |
0.0022 |
| 645 |
HYPOTENSION |
442 |
0.0022 |
| 646 |
ECCHYMOSIS |
15 |
0.0022 |
| 647 |
PRODUCTIVE COUGH |
104 |
0.0022 |
| 648 |
HAEMATURIA |
74 |
0.0022 |
| 649 |
TUMOUR LYSIS SYNDROME |
19 |
0.0022 |
| 650 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
112 |
0.0021 |
| 651 |
SPINAL PAIN |
25 |
0.0021 |
| 652 |
BODY TEMPERATURE DECREASED |
21 |
0.0021 |
| 653 |
HEMIPARESIS |
36 |
0.0021 |
| 654 |
RASH GENERALISED |
55 |
0.0021 |
| 655 |
SKIN LESION |
58 |
0.0021 |
| 656 |
RASH ERYTHEMATOUS |
101 |
0.0021 |
| 657 |
APPETITE DISORDER |
14 |
0.0021 |
| 658 |
SCAB |
24 |
0.0021 |
| 659 |
ERYTHEMA |
428 |
0.0021 |
| 660 |
GASTROINTESTINAL DISORDER |
185 |
0.0021 |
| 661 |
UROSEPSIS |
19 |
0.0021 |
| 662 |
NAIL DISORDER |
18 |
0.0021 |
| 663 |
ORAL PAIN |
46 |
0.0021 |
| 664 |
ABNORMAL LOSS OF WEIGHT |
14 |
0.0021 |
| 665 |
GROIN PAIN |
18 |
0.0020 |
| 666 |
STATUS EPILEPTICUS |
23 |
0.0020 |
| 667 |
TRICUSPID VALVE INCOMPETENCE |
16 |
0.0020 |
| 668 |
DEATH |
1724 |
0.0020 |
| 669 |
COGNITIVE DISORDER |
93 |
0.0020 |
| 670 |
IMMUNE SYSTEM DISORDER |
26 |
0.0020 |
| 671 |
BLOOD POTASSIUM DECREASED |
59 |
0.0020 |
| 672 |
RECTAL HAEMORRHAGE |
84 |
0.0020 |
| 673 |
URINE OUTPUT DECREASED |
17 |
0.0019 |
| 674 |
DYSGEUSIA |
143 |
0.0019 |
| 675 |
SYNCOPE |
191 |
0.0019 |
| 676 |
DERMATITIS ALLERGIC |
24 |
0.0019 |
| 677 |
FATIGUE |
1482 |
0.0019 |
| 678 |
ALTERED STATE OF CONSCIOUSNESS |
41 |
0.0019 |
| 679 |
DIPLOPIA |
49 |
0.0019 |
| 680 |
DEVICE RELATED INFECTION |
29 |
0.0019 |
| 681 |
PULMONARY OEDEMA |
84 |
0.0019 |
| 682 |
OPTIC NEURITIS |
17 |
0.0019 |
| 683 |
JAUNDICE |
50 |
0.0019 |
| 684 |
MYOPATHY |
16 |
0.0019 |
| 685 |
HYPERTENSION |
388 |
0.0018 |
| 686 |
ASPIRATION |
20 |
0.0018 |
| 687 |
ESCHERICHIA INFECTION |
15 |
0.0018 |
| 688 |
RENAL FAILURE CHRONIC |
14 |
0.0018 |
| 689 |
APPENDICITIS |
17 |
0.0018 |
| 690 |
DIFFUSE LARGE B-CELL LYMPHOMA |
14 |
0.0018 |
| 691 |
CARDIAC ARREST |
150 |
0.0018 |
| 692 |
HAEMOLYSIS |
14 |
0.0018 |
| 693 |
CYTOMEGALOVIRUS INFECTION |
30 |
0.0018 |
| 694 |
MYELODYSPLASTIC SYNDROME |
26 |
0.0018 |
| 695 |
CHEST PAIN |
331 |
0.0018 |
| 696 |
DISEASE RECURRENCE |
85 |
0.0018 |
| 697 |
PANCREATITIS |
94 |
0.0018 |
| 698 |
SKIN PLAQUE |
15 |
0.0018 |
| 699 |
BONE PAIN |
104 |
0.0018 |
| 700 |
MUSCULOSKELETAL PAIN |
93 |
0.0018 |
| 701 |
ABDOMINAL PAIN |
412 |
0.0018 |
| 702 |
DEAFNESS |
46 |
0.0018 |
| 703 |
TOXICITY TO VARIOUS AGENTS |
293 |
0.0017 |
| 704 |
BLOOD POTASSIUM INCREASED |
28 |
0.0017 |
| 705 |
DRUG INTOLERANCE |
166 |
0.0017 |
| 706 |
CARPAL TUNNEL SYNDROME |
24 |
0.0017 |
| 707 |
ANGINA PECTORIS |
49 |
0.0017 |
| 708 |
IMMUNOSUPPRESSION |
15 |
0.0017 |
| 709 |
CONFUSIONAL STATE |
274 |
0.0017 |
| 710 |
COUGH |
474 |
0.0017 |
| 711 |
INFLAMMATION |
87 |
0.0017 |
| 712 |
MYOCLONUS |
20 |
0.0017 |
| 713 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
48 |
0.0017 |
| 714 |
HAEMORRHAGE |
171 |
0.0016 |
| 715 |
PSEUDOMONAS INFECTION |
14 |
0.0016 |
| 716 |
PULMONARY HYPERTENSION |
34 |
0.0016 |
| 717 |
RETINAL DETACHMENT |
15 |
0.0016 |
| 718 |
URINARY RETENTION |
54 |
0.0016 |
| 719 |
PYELONEPHRITIS |
14 |
0.0016 |
| 720 |
IMMUNODEFICIENCY |
24 |
0.0016 |
| 721 |
HEPATIC ENCEPHALOPATHY |
15 |
0.0016 |
| 722 |
DYSARTHRIA |
60 |
0.0016 |
| 723 |
REBOUND EFFECT |
18 |
0.0016 |
| 724 |
HYPOTHERMIA |
16 |
0.0016 |
| 725 |
GASTROINTESTINAL HAEMORRHAGE |
131 |
0.0016 |
| 726 |
WEIGHT DECREASED |
436 |
0.0016 |
| 727 |
CENTRAL NERVOUS SYSTEM LESION |
21 |
0.0015 |
| 728 |
BODY TEMPERATURE INCREASED |
31 |
0.0015 |
| 729 |
BLOOD COUNT ABNORMAL |
23 |
0.0015 |
| 730 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
39 |
0.0015 |
| 731 |
INTESTINAL OBSTRUCTION |
57 |
0.0015 |
| 732 |
SKIN ULCER |
39 |
0.0015 |
| 733 |
THROMBOSIS |
121 |
0.0015 |
| 734 |
BACTERIAL INFECTION |
28 |
0.0015 |
| 735 |
COAGULOPATHY |
25 |
0.0015 |
| 736 |
THERAPY NON-RESPONDER |
67 |
0.0015 |
| 737 |
STAPHYLOCOCCAL INFECTION |
49 |
0.0015 |
| 738 |
GASTRIC HAEMORRHAGE |
17 |
0.0015 |
| 739 |
INTERNATIONAL NORMALISED RATIO INCREASED |
42 |
0.0015 |
| 740 |
RASH MACULAR |
51 |
0.0015 |
| 741 |
NODULE |
19 |
0.0015 |
| 742 |
DRUG INTERACTION |
230 |
0.0014 |
| 743 |
ULCER |
23 |
0.0014 |
| 744 |
POOR QUALITY SLEEP |
31 |
0.0014 |
| 745 |
METABOLIC ACIDOSIS |
46 |
0.0014 |
| 746 |
RESPIRATORY DISORDER |
43 |
0.0014 |
| 747 |
PRODUCT USE IN UNAPPROVED INDICATION |
355 |
0.0014 |
| 748 |
RASH PAPULAR |
32 |
0.0014 |
| 749 |
MUSCULAR WEAKNESS |
162 |
0.0014 |
| 750 |
CHRONIC KIDNEY DISEASE |
108 |
0.0014 |
| 751 |
MITRAL VALVE INCOMPETENCE |
16 |
0.0014 |
| 752 |
HYPOTONIA |
14 |
0.0014 |
| 753 |
PRESYNCOPE |
34 |
0.0014 |
| 754 |
NEOPLASM MALIGNANT |
93 |
0.0014 |
| 755 |
SKIN DISCOLOURATION |
64 |
0.0014 |
| 756 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
55 |
0.0014 |
| 757 |
CHILLS |
162 |
0.0014 |
| 758 |
CHEST DISCOMFORT |
141 |
0.0014 |
| 759 |
BLOOD URINE PRESENT |
26 |
0.0014 |
| 760 |
HEPATIC ENZYME INCREASED |
93 |
0.0014 |
| 761 |
TINNITUS |
62 |
0.0013 |
| 762 |
CONDITION AGGRAVATED |
409 |
0.0013 |
| 763 |
HYPERLIPIDAEMIA |
16 |
0.0013 |
| 764 |
DYSURIA |
49 |
0.0013 |
| 765 |
VERTIGO |
81 |
0.0013 |
| 766 |
FLUSHING |
135 |
0.0013 |
| 767 |
UVEITIS |
18 |
0.0013 |
| 768 |
APHASIA |
40 |
0.0013 |
| 769 |
HERPES ZOSTER |
76 |
0.0013 |
| 770 |
DYSPHONIA |
77 |
0.0013 |
| 771 |
TENDON RUPTURE |
16 |
0.0013 |
| 772 |
PRESCRIBED OVERDOSE |
25 |
0.0013 |
| 773 |
PULMONARY CONGESTION |
17 |
0.0013 |
| 774 |
MASS |
18 |
0.0013 |
| 775 |
CEREBROVASCULAR ACCIDENT |
218 |
0.0013 |
| 776 |
CHROMATURIA |
29 |
0.0013 |
| 777 |
PULMONARY THROMBOSIS |
14 |
0.0013 |
| 778 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
22 |
0.0013 |
| 779 |
TASTE DISORDER |
26 |
0.0013 |
| 780 |
ANGIOEDEMA |
56 |
0.0013 |
| 781 |
BLOOD PRESSURE DECREASED |
84 |
0.0013 |
| 782 |
MUSCLE ATROPHY |
16 |
0.0013 |
| 783 |
DIABETES MELLITUS |
95 |
0.0012 |
| 784 |
PULMONARY ARTERIAL HYPERTENSION |
18 |
0.0012 |
| 785 |
PAIN IN JAW |
35 |
0.0012 |
| 786 |
THIRST |
22 |
0.0012 |
| 787 |
URINARY TRACT INFECTION |
209 |
0.0012 |
| 788 |
CORONARY ARTERY DISEASE |
37 |
0.0012 |
| 789 |
SKIN EXFOLIATION |
103 |
0.0012 |
| 790 |
RETCHING |
26 |
0.0012 |
| 791 |
NERVOUS SYSTEM DISORDER |
38 |
0.0012 |
| 792 |
PHOTOSENSITIVITY REACTION |
20 |
0.0012 |
| 793 |
MYOCARDIAL INFARCTION |
209 |
0.0012 |
| 794 |
CHOLELITHIASIS |
39 |
0.0012 |
| 795 |
BACK PAIN |
276 |
0.0012 |
| 796 |
FEEDING DISORDER |
24 |
0.0012 |
| 797 |
FLATULENCE |
67 |
0.0012 |
| 798 |
HEPATIC STEATOSIS |
22 |
0.0012 |
| 799 |
TREATMENT FAILURE |
97 |
0.0012 |
| 800 |
ECZEMA |
61 |
0.0012 |
| 801 |
AGEUSIA |
29 |
0.0012 |
| 802 |
MUSCULOSKELETAL DISCOMFORT |
20 |
0.0012 |
| 803 |
GENERALISED TONIC-CLONIC SEIZURE |
19 |
0.0011 |
| 804 |
POST PROCEDURAL COMPLICATION |
22 |
0.0011 |
| 805 |
ADVERSE EVENT |
105 |
0.0011 |
| 806 |
CARDIOMEGALY |
14 |
0.0011 |
| 807 |
DISORIENTATION |
45 |
0.0011 |
| 808 |
SUBDURAL HAEMATOMA |
16 |
0.0011 |
| 809 |
WHEEZING |
66 |
0.0011 |
| 810 |
PRURITUS |
427 |
0.0011 |
| 811 |
NEURALGIA |
27 |
0.0011 |
| 812 |
BLINDNESS |
45 |
0.0011 |
| 813 |
MALAISE |
482 |
0.0011 |
| 814 |
ARRHYTHMIA |
52 |
0.0011 |
| 815 |
PARAESTHESIA |
172 |
0.0011 |
| 816 |
FULL BLOOD COUNT DECREASED |
22 |
0.0011 |
| 817 |
SEIZURE |
126 |
0.0011 |
| 818 |
CONVULSION |
62 |
0.0011 |
| 819 |
EATING DISORDER |
23 |
0.0011 |
| 820 |
LOWER RESPIRATORY TRACT INFECTION |
49 |
0.0011 |
| 821 |
SKIN FISSURES |
21 |
0.0011 |
| 822 |
ABDOMINAL PAIN LOWER |
27 |
0.0011 |
| 823 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
51 |
0.0011 |
| 824 |
HYPERSENSITIVITY |
197 |
0.0011 |
| 825 |
UNRESPONSIVE TO STIMULI |
27 |
0.0010 |
| 826 |
HYPOACUSIS |
45 |
0.0010 |
| 827 |
BONE DISORDER |
19 |
0.0010 |
| 828 |
UPPER RESPIRATORY TRACT INFECTION |
48 |
0.0010 |
| 829 |
IMPAIRED HEALING |
34 |
0.0010 |
| 830 |
LOCAL SWELLING |
18 |
0.0010 |
| 831 |
CORONARY ARTERY OCCLUSION |
14 |
0.0010 |
| 832 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
182 |
0.0010 |
| 833 |
CEREBRAL HAEMORRHAGE |
36 |
0.0010 |
| 834 |
ELECTROCARDIOGRAM QT PROLONGED |
36 |
0.0010 |
| 835 |
OSTEOPOROSIS |
41 |
0.0010 |
| 836 |
TOOTHACHE |
18 |
0.0010 |
| 837 |
ADVERSE DRUG REACTION |
89 |
0.0010 |
| 838 |
PRODUCT USE ISSUE |
186 |
0.0010 |
| 839 |
MUSCLE TIGHTNESS |
16 |
0.0010 |
| 840 |
DIALYSIS |
14 |
0.0010 |
| 841 |
OROPHARYNGEAL PAIN |
91 |
0.0010 |
| 842 |
THERAPEUTIC RESPONSE DECREASED |
59 |
0.0010 |
| 843 |
ALOPECIA |
189 |
0.0010 |
| 844 |
FLUID OVERLOAD |
14 |
0.0010 |
| 845 |
FUNGAL INFECTION |
32 |
0.0010 |
| 846 |
RHINORRHOEA |
61 |
0.0009 |
| 847 |
RESPIRATORY ARREST |
26 |
0.0009 |
| 848 |
OSTEOMYELITIS |
17 |
0.0009 |
| 849 |
MYALGIA |
159 |
0.0009 |
| 850 |
RHABDOMYOLYSIS |
39 |
0.0009 |
| 851 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
33 |
0.0009 |
| 852 |
BLOOD GLUCOSE ABNORMAL |
17 |
0.0009 |
| 853 |
OSTEONECROSIS |
30 |
0.0009 |
| 854 |
ABDOMINAL DISTENSION |
95 |
0.0009 |
| 855 |
PHARYNGEAL OEDEMA |
14 |
0.0009 |
| 856 |
RENAL INJURY |
27 |
0.0009 |
| 857 |
ABDOMINAL PAIN UPPER |
184 |
0.0009 |
| 858 |
BALANCE DISORDER |
77 |
0.0009 |
| 859 |
URINARY INCONTINENCE |
26 |
0.0009 |
| 860 |
ABSCESS |
14 |
0.0009 |
| 861 |
DRUG INEFFECTIVE |
1155 |
0.0009 |
| 862 |
VISUAL ACUITY REDUCED |
29 |
0.0009 |
| 863 |
VIRAL INFECTION |
29 |
0.0009 |
| 864 |
HAEMATOCHEZIA |
48 |
0.0009 |
| 865 |
TRANSIENT ISCHAEMIC ATTACK |
29 |
0.0009 |
| 866 |
COLD SWEAT |
15 |
0.0009 |
| 867 |
DIZZINESS |
424 |
0.0008 |
| 868 |
HAEMATOMA |
22 |
0.0008 |
| 869 |
HYPERSOMNIA |
24 |
0.0008 |
| 870 |
LETHARGY |
48 |
0.0008 |
| 871 |
FAECES DISCOLOURED |
18 |
0.0008 |
| 872 |
LOSS OF CONSCIOUSNESS |
106 |
0.0008 |
| 873 |
SWELLING FACE |
53 |
0.0008 |
| 874 |
LABORATORY TEST ABNORMAL |
24 |
0.0008 |
| 875 |
COVID-19 |
142 |
0.0008 |
| 876 |
HALLUCINATION, VISUAL |
17 |
0.0008 |
| 877 |
DRY SKIN |
107 |
0.0008 |
| 878 |
DRY MOUTH |
65 |
0.0008 |
| 879 |
DIABETES MELLITUS INADEQUATE CONTROL |
14 |
0.0008 |
| 880 |
BLISTER |
44 |
0.0008 |
| 881 |
FEELING HOT |
48 |
0.0008 |
| 882 |
MOVEMENT DISORDER |
25 |
0.0008 |
| 883 |
COMA |
37 |
0.0008 |
| 884 |
NIGHT SWEATS |
25 |
0.0008 |
| 885 |
PALLOR |
21 |
0.0008 |
| 886 |
BRONCHITIS |
57 |
0.0008 |
| 887 |
HAEMORRHOIDS |
15 |
0.0008 |
| 888 |
DISCOMFORT |
46 |
0.0008 |
| 889 |
INTENTIONAL PRODUCT USE ISSUE |
66 |
0.0008 |
| 890 |
SPINAL FRACTURE |
15 |
0.0007 |
| 891 |
DYSPEPSIA |
73 |
0.0007 |
| 892 |
FRACTURE |
14 |
0.0007 |
| 893 |
OCULAR HYPERAEMIA |
35 |
0.0007 |
| 894 |
HYPERHIDROSIS |
95 |
0.0007 |
| 895 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
40 |
0.0007 |
| 896 |
HEART RATE INCREASED |
72 |
0.0007 |
| 897 |
PALPITATIONS |
85 |
0.0007 |
| 898 |
RESTLESSNESS |
26 |
0.0007 |
| 899 |
CARDIAC FAILURE CONGESTIVE |
57 |
0.0007 |
| 900 |
HYPOGLYCAEMIA |
34 |
0.0007 |
| 901 |
SOMNOLENCE |
140 |
0.0007 |
| 902 |
URTICARIA |
116 |
0.0007 |
| 903 |
NECK PAIN |
38 |
0.0007 |
| 904 |
ARTHRALGIA |
281 |
0.0007 |
| 905 |
HYPOAESTHESIA |
101 |
0.0007 |
| 906 |
ARTHRITIS |
53 |
0.0007 |
| 907 |
POLLAKIURIA |
28 |
0.0007 |
| 908 |
COLITIS ULCERATIVE |
30 |
0.0007 |
| 909 |
FLUID RETENTION |
34 |
0.0007 |
| 910 |
THROAT TIGHTNESS |
18 |
0.0007 |
| 911 |
PAIN |
406 |
0.0007 |
| 912 |
EYE PRURITUS |
22 |
0.0007 |
| 913 |
GAIT DISTURBANCE |
124 |
0.0006 |
| 914 |
CLOSTRIDIUM DIFFICILE INFECTION |
14 |
0.0006 |
| 915 |
PERIPHERAL SWELLING |
98 |
0.0006 |
| 916 |
DRUG EFFECT INCOMPLETE |
23 |
0.0006 |
| 917 |
LOCALISED INFECTION |
15 |
0.0006 |
| 918 |
DYSSTASIA |
18 |
0.0006 |
| 919 |
ILL-DEFINED DISORDER |
37 |
0.0006 |
| 920 |
WOUND |
17 |
0.0006 |
| 921 |
HEADACHE |
379 |
0.0006 |
| 922 |
LIP SWELLING |
20 |
0.0006 |
| 923 |
PAIN IN EXTREMITY |
176 |
0.0006 |
| 924 |
TYPE 2 DIABETES MELLITUS |
20 |
0.0006 |
| 925 |
EYE SWELLING |
22 |
0.0006 |
| 926 |
RHEUMATOID ARTHRITIS |
67 |
0.0006 |
| 927 |
JOINT SWELLING |
71 |
0.0006 |
| 928 |
GASTROOESOPHAGEAL REFLUX DISEASE |
47 |
0.0006 |
| 929 |
VISION BLURRED |
80 |
0.0006 |
| 930 |
FALL |
193 |
0.0006 |
| 931 |
VAGINAL HAEMORRHAGE |
25 |
0.0006 |
| 932 |
SPEECH DISORDER |
30 |
0.0006 |
| 933 |
FEMUR FRACTURE |
17 |
0.0005 |
| 934 |
HOSPITALISATION |
84 |
0.0005 |
| 935 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
16 |
0.0005 |
| 936 |
BLOOD GLUCOSE INCREASED |
100 |
0.0005 |
| 937 |
SWELLING |
48 |
0.0005 |
| 938 |
HEART RATE DECREASED |
18 |
0.0005 |
| 939 |
BLOOD PRESSURE INCREASED |
78 |
0.0005 |
| 940 |
GAIT INABILITY |
17 |
0.0005 |
| 941 |
FEELING COLD |
14 |
0.0005 |
| 942 |
CYSTITIS |
16 |
0.0005 |
| 943 |
DRY EYE |
25 |
0.0005 |
| 944 |
SLEEP DISORDER |
35 |
0.0005 |
| 945 |
LACTIC ACIDOSIS |
16 |
0.0005 |
| 946 |
DEPRESSION |
109 |
0.0005 |
| 947 |
BRADYCARDIA |
25 |
0.0005 |
| 948 |
INFLUENZA |
52 |
0.0005 |
| 949 |
HOT FLUSH |
35 |
0.0005 |
| 950 |
INSOMNIA |
123 |
0.0005 |
| 951 |
INFLUENZA LIKE ILLNESS |
38 |
0.0005 |
| 952 |
VISUAL IMPAIRMENT |
57 |
0.0005 |
| 953 |
MEDICATION ERROR |
25 |
0.0004 |
| 954 |
AGITATION |
33 |
0.0004 |
| 955 |
WEIGHT INCREASED |
98 |
0.0004 |
| 956 |
ANXIETY |
122 |
0.0004 |
| 957 |
TREMOR |
71 |
0.0004 |
| 958 |
DISTURBANCE IN ATTENTION |
23 |
0.0004 |
| 959 |
MOBILITY DECREASED |
29 |
0.0004 |
| 960 |
TREATMENT NONCOMPLIANCE |
22 |
0.0004 |
| 961 |
THROAT IRRITATION |
18 |
0.0004 |
| 962 |
EYE IRRITATION |
22 |
0.0004 |
| 963 |
DEPRESSED MOOD |
20 |
0.0004 |
| 964 |
SKIN BURNING SENSATION |
27 |
0.0004 |
| 965 |
CONTUSION |
36 |
0.0004 |
| 966 |
HALLUCINATION |
28 |
0.0004 |
| 967 |
SINUSITIS |
38 |
0.0004 |
| 968 |
NEPHROLITHIASIS |
17 |
0.0004 |
| 969 |
ABDOMINAL DISCOMFORT |
60 |
0.0004 |
| 970 |
OSTEOARTHRITIS |
15 |
0.0004 |
| 971 |
BURNING SENSATION |
24 |
0.0003 |
| 972 |
PSORIASIS |
43 |
0.0003 |
| 973 |
ARTHROPATHY |
18 |
0.0003 |
| 974 |
CARDIAC DISORDER |
30 |
0.0003 |
| 975 |
AMNESIA |
20 |
0.0003 |
| 976 |
AGGRESSION |
15 |
0.0003 |
| 977 |
MUSCULOSKELETAL STIFFNESS |
24 |
0.0003 |
| 978 |
NASAL CONGESTION |
16 |
0.0003 |
| 979 |
NASOPHARYNGITIS |
49 |
0.0003 |
| 980 |
ACNE |
20 |
0.0003 |
| 981 |
MEMORY IMPAIRMENT |
36 |
0.0003 |
| 982 |
FEELING ABNORMAL |
61 |
0.0003 |
| 983 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
18 |
0.0003 |
| 984 |
CATARACT |
15 |
0.0003 |
| 985 |
UNDERDOSE |
17 |
0.0002 |
| 986 |
MUSCLE SPASMS |
41 |
0.0002 |
| 987 |
OVERDOSE |
44 |
0.0002 |
| 988 |
INCORRECT DOSE ADMINISTERED |
46 |
0.0002 |
| 989 |
INTENTIONAL PRODUCT MISUSE |
17 |
0.0002 |
| 990 |
ASTHMA |
18 |
0.0002 |
| 991 |
NO ADVERSE EVENT |
27 |
0.0001 |
| 992 |
ILLNESS |
14 |
0.0001 |
| 993 |
EMOTIONAL DISTRESS |
15 |
0.0001 |
| 994 |
PRODUCT DOSE OMISSION ISSUE |
29 |
0.0001 |
| 995 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
18 |
0.0001 |